The thyroid and the gut

Journal of Clinical Gastroenterology

Volumn 44, Issue 6, 2010, Pages 402-406

  Ebert, Ellen C ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

ascites; autoimmune; constipation; diarrhea; gastritis; motility

Indexed keywords

ABDOMINAL DISCOMFORT; ASCITES; BACTERIAL OVERGROWTH; BLOATING; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DIARRHEA; DYSPEPSIA; DYSPHAGIA; ESOPHAGUS FUNCTION DISORDER; FLATULENCE; GASTRIN BLOOD LEVEL; GASTRITIS; GRAVES DISEASE; HASHIMOTO DISEASE; HEARTBURN; HYPERGASTRINEMIA; HYPERPHAGIA; HYPERTHYROIDISM; HYPOTHYROIDISM; ILEUS; MEGACOLON; MYXEDEMA; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSEUDOOBSTRUCTION; REVIEW; STEATORRHEA; STOMACH EMPTYING; THYROID DISEASE; THYROID MEDULLARY CARCINOMA; THYROTOXICOSIS; VOMITING; COMPLICATION; GASTROINTESTINAL MOTILITY; HUMAN; INTESTINAL DISEASES; PATHOPHYSIOLOGY; PHYSIOLOGY;

GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL DISEASES; THYROID DISEASES;

EID: 77953810322     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181d6bc3e     Document Type: Review

References (84)

1. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol. 1977;7:481-493.
2. Falkenberg M, Kagedal B, Norr A. Screening of an elderly female population for hypo-and hyperthyroidism by use of a thyroid hormone panel. Acta Med Scand. 1983;214:361-365.
3. Nishimura H, Kino M, Kubo S, et al. Hashimoto's thyroiditis and ulcerative colitis in a patient with Turner's syndrome. JAMA. 1985;254:357.
4. Shah S, Peppercorn MA, Pallotta JA. Autoimmune (Hashimoto's) thyroiditis associated with Crohn's disease. J Clin Gastroenterol. 1998;26:117-120.
5. Crowe JP, Christensen E, Butler J, et al. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology. 1980;78:1437.
6. Doniach D, Roitt IM, Taylor KB. Autoimmune phenomena in pernicious anemia. Brit Med J. 1963;1:1374.
7. Markson JL, Moore JM. Thyroid auto-antibodies in pernicious anemia. Brit Med J. 1962;2:1352.
8. Landing BH, Pettit MD, Weins RL, et al. Antithyroid antibodies and chronic thyroiditis in diabetes mellitus. J Clin Endocr Metab. 1963;23:119-120.
9. Counsell CE, Taha A, Ruddell WS. Coeliac disease and autoimmune thyroid disease. Gut. 1994;35:844-846.
10. Watanakunakorn C, Hodges RE, Evans TC. Myxedema. Arch Intern Med. 1965;116:183-190.
11. Bassotti G, Pagliacci MC, Nicoletti I, et al. Intestinal pseudoobstruction secondary to hypothyroidism. Importance of small bowel manometry. J Clin Gastroenterol. 1992;14:56-58.
12. Eastwood GL, Braverman LE, White EM, et al. Reversal of lower esophageal sphincter hypotension and esophageal aperistalsis after treatment for hypothyroidism. J Clin Gastroenterol. 1982;4:307-310.
13. Dotevall G, Rohrer V, Stefco P, et al. Relationship between gastric and thyroid function. Am J Dig Dis. 1967;12:1230-1239.
14. Seino Y, Matsukura S, Inoue Y, et al. Hypogastrinemia in hypothyroidism. Am J Dig Dis. 1978;23:189-191.
15. Gunsar F, Yilmaz S, Bor S, et al. Effect of hypo-and hyperthyroidism on gastric myoelectrical activity. Dig Dis Sci. 2003;48:706-712.
16. Kahrman H, Kaya N, Demircali A, et al. Gastric emptying time in patients with primary hypothyroidism. Eur J Gastroenterol Hepatol. 1997;9:901-904.
17. Kao PF, Lin JD, Chiu CT, et al. Gastric emptying function changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. J Gastroenterol Hepatol. 2004;19: 655-660.
18. Kaplan LR. Hypothyroidism presenting as gastric phytobezoar. Am J Gastroenterol. 1980;74:168-169.
19. Mangold D, Woolam GL, Garcia-Rinaldi R. Intestinal obstruction due to phytobezoars. Arch Surg. 1978;113:1001-1003.
20. Tobin MV, Fisken RA, Diggory RT, et al. Orocaecal transit in health and in thyroid disease. Gut. 1989;30:26-29.
21. Shafer RB, Prentiss RA, Bond JH. Gastrointestinal transit in thyroid disease. Gastroenterology. 1984;86:852-855.
22. Lauritano EC, Bilotta AL, Gabrielli M, et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab. 2007;92:4180-4184. (Pubitemid 350074729)
23. Lake-Bakaar G. Hypothyroidism and functional bowel disease. Am J Med. 1990;88:312-313.
24. Baker JT, Harvey RF. Bowel habit in thyrotoxicosis and hypothyroidism. Br Med J. 1971;1:322-323.
25. Abbasi AA, Douglass RC, Bissell GW, et al. Myxedema ileus. A form of intestinal pseudo-obstruction. JAMA. 1975;234: 181-183.
26. Bacharach T, Evans JR. Enlargement of the colon secondary to hypothyroidism. Ann Int Med. 1957;47:121-124.
27. Batalis T, Muers M, Royle GT. Treatment with intravenous triiodothyronine of colonic pseudo-obstruction caused by myxoedema. Br J Surg. 1981;68:439.
28. Patel R, Hughes RW. An unusual case of myxedema megacolon with features of ischemic and pseudomembranous colitis. Mayo Clin Proc. 1992;67:369-372.
29. Kale VR, Woodward DAK. Ischaemic colitis due to myxoedema (letter to the editor). Br Med J. 1974;3:42-43.
30. Cole P, Petrie JC, Bewsher PD. Intestinal obstruction and hypothyroidism. Br Med J. 1969;3:655-656.
31. Fukunaga K. Refractory gastrointestinal bleeding treated with thyroid hormone replacement. J Clin Gastroenterol. 2001;33: 145-147.
32. Burrell M, Cronan J, Megna D, et al. Myxedema megacolon. Gastrointest Radiol. 1980;5:181-186.
33. Wells I, Smith B, Hinton M. Acute ileus in myxoedema. Br Med J. 1977;1:211-212.
34. Douglass RC, Jacobson SD. Pathologic changes in adult myxedema: survey of 10 necropsies. J Clin Endocrinol Metab. 1957;17:1354-1364.
35. Chadha JS, Ashby DW, Cowan WK. Fatal intestinal atony in myxoedema. Br Med J. 1969;3:398.
36. Duret RL, Bastenie PA. Intestinal disorders in hypothyroidism. Clinical and manometric study. Dig Dis Sci. 1971;16: 723-727.
37. Bergeron E, Mitchell A, Heyen F, et al. Acute colonic surgery and unrecognized hypothyroidism: a warning. Dis Colon Rectum. 1997;40:859-861.
38. Aun F, Medeiros-Neto GA, Younes RN, et al. The effect of major trauma on the pathways of thyroid hormone metabolism. J Trauma. 1983;23:1048-1051.
39. Haley HB, Leigh C, Bronsky D, et al. Ascites and intestinal obstruction in myxedema. Arch Surg. 1962;85:328-332.
40. Kocen RS, Atkinson M. Ascites in hypothyroidism. Lancet. 1963;1:527-530.
41. Braunwald E, Fauci AS, Kasper DL, et al. Harrison's Principles of Internal Medicine. 15th ed. McGraw-Hill Medical Publishing; 2001:2069.
42. Rosenthal FD, Jones CC, Lewis SI. Thyrotoxic vomiting. Br Med J. 1976;2:209-211.
43. Anderson JR, Gray KG, Middleton DG, et al. Autoimmunity and thyrotoxicosis. Br Med J. 1964;2:1630-1632.
44. Modeb O. Autoimmune thyroid disease with ulcerative colitis. Postgrad Med J. 1986;62:475-476.
45. Noto H, Mitsuhashi T, Ishibashi S, et al. Hyperthyroidism presenting as dysphagia. Int Med. 2000;39:472-473.
46. Pfaffenbach B, Adamek RJ, Hagelmann D, et al. Effect of hyperthyroidism on antral myoelectrical activity, gastric emptying and dyspepsia in man. Hepato-Gastroenterol. 1997; 44:1500-1508.
47. Jonderko K, Jonderko G, Marcisz C, et al. Gastric emptying in hyperthyroidism. Am J Gastroenterol. 1997;92:835-838.
48. Wegener M, Wedmann B, Langhoff T, et al. Effect of hyperthyroidism on the transit of a caloric solid-liquid meal through the stomach, the small intestine, and the colon in man. J Clin Endocrinol Metab. 1992;75:745-749.
49. Christensen J, Schedl HP, Clifton JA. The basic electrical rhythm of the duodenum in normal human subjects and in patients with thyroid disease. J Clin Invest. 1964;43:1659-1667.
50. Miller LJ, Owyang C, Malagelada JR, et al. Gastric, pancreatic, and biliary responses to meals in hyperthyroidism. Gut. 1980;21:695-700.
51. Holdsworth CD, Besser GM. Influence of gastric emptying rate and of insulin response on oral glucose tolerance in thyroid disease. Lancet. 1968;2:700-702.
52. Groskreutz JL, Kim CH, McConahey WM. Acute gastroparesis associated with thyrotoxicosis. Am J Gastroenterol. 1990;85: 1206-1207.
53. Williams MJ, Blair DW. Gastric secretion in hyperthyroidism. Br Med J. 1964;1:940-944.
54. Seino Y, Matsukura S, Miyamoto Y, et al. Hypergastrinemia in hyperthyroidism. J Clin Endocrinol Metab. 1976;43:852-855.
55. Williams MJ, Scott GB, Beck JS, et al. Antigastric antibodies in hyperthyroidism: their relationship to impaired acid secretion. Br Med J. 1966;1:388-391.
56. Gillespie IE, Bowen DJ. The gastric secretion of pepsin in man. Gut. 1962;3:255-259.
57. Wiersinga WM, Touber JL. The relation between gastrin, gastric acid and thyroid function disorders. Acta Endocrinologica. 1980;95:341-349.
58. Wiley ZD, Lavigne ME, Lin KM, et al. The effect of hyperthyroidism on gastric emptying rates and pancreatic exocrine and biliary secretion in man. Am J Dig Dis. 1978;23:1003-1008.
59. Hellstrom K, Lindstedt S. Cholic-acid turnover and biliary bile-acid composition in humans with abnormal thyroid function. J Lab Clin Med. 1964;63:666-679.
60. Thomas FB, Caldwell JH, Greenberger NJ. Steatorrhea in thyrotoxicosis. Relation to hypermotility and excessive dietary fat. Ann Int Med. 1973;78:669-675.
61. Scarf M. Gastrointestinal manifestations of hyperthyroidism. J Lab Clin Med. 1936;21:1253-1268.
62. Shirer JW. Hypermotility of the gastrointestinal tract in hyperthyroidism. Am J Med Sci. 1933;186:73-78.
63. Bozzani A, Camboni MG, Tidone L, et al. Gastrointestinal transit in hyperthyroid patients before and after propranolol treatment. Am J Gastroenterol. 1985;80:550-552.
64. Papa A, Cammarota G, Tursi A, et al. Effects of propylthiouracil on intestinal transit time and symptoms in hyperthyroid patients. Hepato-Gastroenterology. 1997;44:426-429.
65. Celano P, Jumawan J, Koldovsky O. Thyroxine-evoked decrease in jejunal lactase activity in adult rats. Gastroenterology. 1977;73:425-428.
66. Broitman SA, Bondy DCC, Yacchnin I, et al. Absorption and disposition of D-xylose in thyrotoxicosis and myxedema. N Engl J Med. 1964;270:333-337.
67. Hill CS, Ibanez ML, Samaan NA, et al. Medullary (solid) carcinoma of the thyroid gland: an analysis of the MD Anderson Hospital experience with patients with the tumor, its special features, and its histogenesis. Medicine. 1973;52: 141-171.
68. Steinfeld CM, Moertel CG, Woolner LB. Diarrhea and medullary carcinoma of the thyroid. Cancer. 1973;31:1237-1239.
69. Kisloff B, Moore EW. Effects of intravenous calcitonin on water, electrolyte, and calcium movement across in vivo rabbit jejunum and ileum. Gastroenterology. 1977;72:462-468.
70. Gray TK, Bieberdorf FA, Fordtran JS. Thyrocalcitonin and the jejunal absorption of calcium, water, and electrolytes in normal subjects. J Clin Invest. 1975;52:3084-3088.
71. Cox TM, Fagan EA, Hillyard CJ, et al. Role of calcitonin in diarrhea associated with medullary carcinoma of the thyroid. Gut. 1979;20:629-633.
72. Williams ED, Karim SM, Sandler M. Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated diarrhea. Lancet. 1968;1:22-23.
73. Bernier JJ, Rambaud JC, Cattan D, et al. Diarrhoea associated with medullary carcinoma of the thyroid. Gut. 1969;10: 980-985.
74. Cummings JH, Newman A, Misiewicz JJ, et al. Effect of intravenous prostaglandin F2 on small intestinal function in man. Nature. 1973;243:169-171.
75. Barrowman JA, Bennett A, Hillenbrand P, et al. Diarrhoea in thyroid medullary carcinoma: role of prostaglandins and therapeutic effect of nutmeg. Br Med J. 1975;iii:11-12.
76. Isaacs P, Whittaker SM, Turnberg LA. Diarrhea associated with medullary carcinoma of the thyroid. Studies of intestinal function in a patient. Gastroenterology. 1974;67:521-526.
77. Rasmusson B. Gastro-intestinal polypeptides in patients treated for medullary carcinoma of the thyroid. Acta Endocrinologica. 1984;106:112-115.
78. Rambaud JC, Jian R, Flourie B, et al. Pathophysiological study of diarrhea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit time. Gut. 1988;29:537-543.
79. Alfonso A, Christoudias G, Amaruddin Q, et al. Tracheal or esophageal compression due to benign thyroid disease. Am J Surg. 1981;142:350-354.
80. Breaux EP, Guillamondegui OM. Treatment of locally invasive carcinoma of the thyroid: how radical? Am J Surg. 1980;140: 514-517.
81. McCaffrey JC. Evaluation and treatment of aerodigestive tract invasion by well-differentiated thyroid carcinoma. Cancer Control. 2000;7:246-252.
82. Machens A, Hinze R, Lautenschlager C, et al. Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications. Surgery. 2001;129:23-28.
83. Wang J, Takashima S, Matsushita T, et al. Esophageal invasion by thyroid carcinomas: prediction using magnetic resonance imaging. J Comput Assist Tomography. 2003;27: 18-25.
84. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proceedings. 1986;61:978-996.